SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-16-788244
Filing Date
2016-12-08
Accepted
2016-12-08 12:15:32
Documents
1
Group Members
ALKEK & WILLIAMS VENTURES LTD.CHASWIL, LTD.DANIEL C. ARNOLDDLD FAMILY INVESTMENTS, LLCJOE M. BAILEYRANDA DUNCAN WILLIAMSSCOTT B. SEAMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d292683dsc13da.htm SC 13D/A 153690
  Complete submission text file 0001193125-16-788244.txt   155734
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 162040827
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1100 LOUISIANA ST., SUITE 5250 HOUSTON TX 77002
Business Address 1100 LOUISIANA ST., SUITE 5250 HOUSTON TX 77002 713-652-6601
Albert & Margaret Alkek Foundation (Filed by) CIK: 0001359867 (see all company filings)

IRS No.: 760491186 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A